Market Overview:
The global atopic dermatitis therapeutics market is expected to grow from USD 7.5 billion in 2018 to USD 12.8 billion by 2030, at a CAGR of 6.3% during the forecast period. The growth of this market is mainly attributed to the increasing prevalence of atopic dermatitis, rising awareness about available treatment options, and growing demand for novel therapies. Based on type, the global atopic dermatitis therapeutics market is segmented into topical agents and systemic therapies. The topical agents segment is further divided into corticosteroids, calcineurin inhibitors (CNIs), pimecrolimus, tacrolimus ointment/creams/lotion/foam; moisturizers; barrier repair products; antihistamines; and anthralin preparations. The systemic therapies segment includes cyclosporine A (CsA), azathioprine (AZA), mycophenolate mofetil (MMF), methotrexate (MTX), leflunomide (LEF) et al., ibrutinib mesylate tablets are also used as systemic therapy for moderate-to-severe AD patients who are intolerant or refractory to other treatments such as CsA or MTX . Based on application, the global atopic dermatitis therapeutics market is segmented into adult and child segments.
Product Definition:
Atopic dermatitis (AD) is a chronic, relapsing, inflammatory skin condition characterized by intense itching and eczematous lesions. AD is the most common form of eczema, affecting approximately 17 million people in the United States. The disease can severely impact quality of life and may be associated with significant psychological morbidity. There is currently no cure for atopic dermatitis, but a variety of treatments are available to manage symptoms.
Atopic dermatitis therapeutics refers to the medications and other treatments used to manage this condition.
Topical Agents:
Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a high prevalence in the pediatric and adult population. The pathogenesis of this disease is not completely understood, but it has been suggested that it may be due to an abnormal response to environmental stimuli. The most commonly used medications for AD include topical agents such as corticosteroids, calcineurin inhibitors, and 5-ALA.
Systemic Therapies:
Systemic therapies are the drugs used for the treatment of atopic dermatitis that have a wide range of adverse effects. The most common side-effects include drowsiness, headache, and nausea among others. These drugs can also lead to drug resistance which is expected to restrain market growth during the forecast period.
Application Insights:
On the basis of application, the global atopic dermatitis therapeutics market is segmented into adult and child. The adult segment held a major share in 2017 due to increasing prevalence of atopic dermatitis coupled with advanced level of awareness among patients regarding available treatment options. Moreover, growing R&D activities for development of novel drugs for AD therapy will boost market growth during the forecast period.
The child segment is expected to witness lucrative growth over the forecast period owing to rising incidence rate and preference for pediatric formulations in various parts of the world including North America, Europe and Asia Pacific regions. In addition, government initiatives such as ¢â‚¬Å“It's My Duty To Inform¢â‚¬ campaign by National Health Mission (NHM) in India are aimed towards improving healthcare accessibility especially for children which will further propel demand from this sector over next few years.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of atopic dermatitis and growing awareness about various treatment options. In addition, presence of key players such as Johnson & Johnson; Merck & Co., Inc.; Pfizer, Inc.; and Allergan Plc will also help maintain dominance of this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income coupled with improving healthcare infrastructure in emerging countries such as China and India will drive growth during the forecast period.
Growth Factors:
- Increasing prevalence of atopic dermatitis
- Growing awareness about atopic dermatitis and its treatment options
- Rising demand for better and more effective therapies for atopic dermatitis
- increasing research and development activities in the field of atopic dermatitis therapeutics 5. growing number of collaborations between pharmaceutical companies and research institutes to develop new therapies for atopic dermatitis
Scope Of The Report
Report Attributes
Report Details
Report Title
Atopic Dermatitis Therapeutics Market Research Report
By Type
Topical Agents, Systemic Therapies
By Application
Adult, Child
By Companies
Sanofi, Astellas, Novartis, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Atopic Dermatitis Therapeutics Market Report Segments:
The global Atopic Dermatitis Therapeutics market is segmented on the basis of:
Types
Topical Agents, Systemic Therapies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Child
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Astellas
- Novartis
- Pfizer
Highlights of The Atopic Dermatitis Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Topical Agents
- Systemic Therapies
- By Application:
- Adult
- Child
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Atopic Dermatitis Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Atopic Dermatitis Therapeutics is a biotechnology company focused on the development of novel therapeutics for atopic dermatitis (AD). AD is a chronic, relapsing skin condition that affects up to 15% of children and adults in developed countries. The most common symptoms are dryness, redness, and itching. AD can be very debilitating and lead to social isolation. There is currently no cure for AD, but there are treatments available that improve symptoms. Atopic Dermatitis Therapeutics' goal is to develop novel therapeutics that address the underlying cause of AD by targeting specific mechanisms involved in inflammation and itchiness.
Some of the major players in the atopic dermatitis therapeutics market are Sanofi, Astellas, Novartis, Pfizer.
The atopic dermatitis therapeutics market is expected to register a CAGR of 6.3%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Atopic Dermatitis Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Atopic Dermatitis Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Atopic Dermatitis Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Atopic Dermatitis Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Atopic Dermatitis Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Atopic Dermatitis Therapeutics Market Size and Y-o-Y Growth
4.5.2 Atopic Dermatitis Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Atopic Dermatitis Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Atopic Dermatitis Therapeutics Market Size Forecast by Type
5.2.1 Topical Agents
5.2.2 Systemic Therapies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Atopic Dermatitis Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Atopic Dermatitis Therapeutics Market Size Forecast by Applications
6.2.1 Adult
6.2.2 Child
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Atopic Dermatitis Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Atopic Dermatitis Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Atopic Dermatitis Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Atopic Dermatitis Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Atopic Dermatitis Therapeutics Market Size Forecast by Type
9.6.1 Topical Agents
9.6.2 Systemic Therapies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Atopic Dermatitis Therapeutics Market Size Forecast by Applications
9.10.1 Adult
9.10.2 Child
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Atopic Dermatitis Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Atopic Dermatitis Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Atopic Dermatitis Therapeutics Market Size Forecast by Type
10.6.1 Topical Agents
10.6.2 Systemic Therapies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Atopic Dermatitis Therapeutics Market Size Forecast by Applications
10.10.1 Adult
10.10.2 Child
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Atopic Dermatitis Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Atopic Dermatitis Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Atopic Dermatitis Therapeutics Market Size Forecast by Type
11.6.1 Topical Agents
11.6.2 Systemic Therapies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Atopic Dermatitis Therapeutics Market Size Forecast by Applications
11.10.1 Adult
11.10.2 Child
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Atopic Dermatitis Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Atopic Dermatitis Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Atopic Dermatitis Therapeutics Market Size Forecast by Type
12.6.1 Topical Agents
12.6.2 Systemic Therapies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Atopic Dermatitis Therapeutics Market Size Forecast by Applications
12.10.1 Adult
12.10.2 Child
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Atopic Dermatitis Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Atopic Dermatitis Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Atopic Dermatitis Therapeutics Market Size Forecast by Type
13.6.1 Topical Agents
13.6.2 Systemic Therapies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Atopic Dermatitis Therapeutics Market Size Forecast by Applications
13.10.1 Adult
13.10.2 Child
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Atopic Dermatitis Therapeutics Market: Competitive Dashboard
14.2 Global Atopic Dermatitis Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Astellas
14.3.3 Novartis
14.3.4 Pfizer
